Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Dec 22, 2020

Dr. David Solomon, CEO, Pharnext is deploying their innovative drug discovery platform that uses genetic data, big data and AI to determine combinations that are novel and non-obvious to find treatments for rare diseases.  With a focus on Charcot-Marie-Tooth, a rare neurologic peripheral neuropathy with no current...


Dec 22, 2020

Dr. David Solomon, CEO, Pharnext is deploying their innovative drug discovery platform that uses genetic data, big data and AI to determine combinations that are novel and non-obvious to find treatments for rare diseases.  With a focus on Charcot-Marie-Tooth, a rare neurologic peripheral neuropathy with no current...


Oct 14, 2020

Jill Sisco, President, Acromegaly Community talks about her experience with acromegaly beginning in her early twenties. She reveals how difficult it is to diagnose this condition, available therapies, and advancements in turning injectable medications into oral treatments. As a patient advocate for those who suffer from...


Oct 14, 2020

Jill Sisco, President, Acromegaly Community talks about her experience with acromegaly beginning in her early twenties. She reveals how difficult it is to diagnose this condition, available therapies, and advancements in turning injectable medications into oral treatments. As a patient advocate for those who suffer from...


Sep 17, 2020

Raj Kannan, CEO, Chiasma is focused on bringing to market oral formulations to patients that face significant challenges with their existing injectable therapies.  Targeting those suffering from the rare disease acromegaly, recent approval of MYCAPSSA brings the first and only oral somatostatin analog to a predominantly...